MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Nagi Bioscience

Nagi Bioscience aims to revolutionize the way toxic/beneficial effects of substances are tested today, with the first “Organism-on-Chip” technology. This combines the use of microscopic worms as in vivo models for drug/chemical screening with the first all-in-one device for their automated in vitro handling and use. Finally, “in vivo testing at the in vitro scale”: ethical alternative to animal testing and key to boost innovation and efficiency in pharma, cosmetic, and chemical industries.
We aim to set a new standard for testing toxicity and efficacy of drugs, cosmetics and chemicals: the first “Organism-on-Chip” technology

Connect with Nagi Bioscience

Nagi Bioscience

2018

2018 Finalist Switzerland

Sub industry

Medical Devices

Additional Industries
Healthcare

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.